Abstract
BackgroundIdentifying potential predictive biomarkers for immune related adverse events (irAEs) following checkpoint blockade inhibition (CPI) remains an outstanding goal of immune-oncology translational research. Polymorphism with the T cell receptor variable...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have